FGFR2 Inhibition in Cholangiocarcinoma

Overview of attention for article published in Annual Review of Medicine, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 50 X posts from 44 X users, with an upper bound of 93,501 followers.

16)胆道癌FGFR2のAnnual reviews https://t.co/cxWKAEHWtv

RT @ArndtVogel: 🔥Just published: FGFR2 Inhibition in Cholangiocarcinoma @AnnualReviews https://t.co/Mx6L7IQr9K 👉we provide an overview of…

RT @ArndtVogel: 🔥Just published: FGFR2 Inhibition in Cholangiocarcinoma @AnnualReviews https://t.co/Mx6L7IQr9K 👉we provide an overview of…

RT @ArndtVogel: 🔥Just published: FGFR2 Inhibition in Cholangiocarcinoma @AnnualReviews https://t.co/Mx6L7IQr9K 👉we provide an overview of…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 46 additional X posts.